Former Chair of Medicine at Cedars-Sinai Medical Center Glenn D. Braunstein, M.D., Joins Pathway Genomics’ Medical Advisory Board

SAN DIEGO--()--Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that world-renowned endocrinologist Dr. Glenn D. Braunstein has joined Pathway Genomics’ medical advisory board. Dr. Braunstein is currently the vice president of clinical innovation, director of the Thyroid Cancer Center and professor of medicine at Cedars-Sinai. For 26 years he served as chair of the Department of Medicine at Cedars-Sinai, and holds the James R. Klinenberg, M.D., Chair in Medicine.

“We are honored to have Dr. Braunstein on our medical advisory board, and we look forward to his expert contributions as we rapidly grow our commercial and research divisions,” said Jim Plante, Pathway Genomics’ founder and CEO. “His vast knowledge and veteran experience in medicine will help us continue to enhance and deliver clinically useful genetic tests to physicians and patients.”

Dr. Braunstein is a member of a number of academic organizations, including the Endocrine Society, the American Thyroid Association, the American Society for Clinical Investigation and the Association of American Physicians. He is a past chair of the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration (FDA) and currently serves as special advisor. Dr. Braunstein also served as chair of the Endocrinology, Diabetes and Metabolism Subspecialty Boards for the American Board of Internal Medicine. The recipient of numerous awards, Dr. Braunstein was named "Top Endocrinologist" by the Los Angeles Business Journal.

"Actionable and accurate genetic testing is becoming a useful tool for physicians in the delivery of quality health care today," said Dr. Braunstein. "It’s exciting to be involved with Pathway Genomics as the practice of medicine transitions from 'one-size-fits-all' to a more personalized care based on each patient's unique genetic traits.”

Serving on the editorial board for American Family Physician, American Journal of Medicine and Reviews in Endocrinology and Metabolism, Dr. Braunstein has published more than 200 peer-reviewed manuscripts, monographs, chapters and reviews dealing with human chorionic gonadotropin, pregnancy, testicular and ovarian physiology and pathophysiology, pituitary and thyroid disorders as well as health care delivery.

Dr. Braunstein earned both his bachelor's and medical degree from the University of California, San Francisco. He completed his internship and residency at Peter Bent Brigham Hospital, Harvard University Medical School. In addition, Dr. Braunstein completed training in endocrinology at the National Institutes of Health and Harbor General Hospital-UCLA School of Medicine.

About Pathway Genomics Corporation

As a CLIA and CAP accredited clinical laboratory based in San Diego, California, Pathway Genomics provides physicians and their patients with actionable and accurate genetic information to improve or maintain health and wellness. Since its founding in 2008, Pathway Genomics has become known for its dedication to innovation and commitment to medical responsibility – making it a leader in the commercial genetic testing industry. Pathway Genomics’ testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit www.pathway.com.

Contacts

Pathway Genomics
Zak Pugh, 858-217-4358
pr@pathway.com
www.pathway.com

Release Summary

Former Chair of Medicine at Cedars-Sinai Medical Center Glenn D. Braunstein, M.D., Joins Pathway Genomics’ Medical Advisory Board

Contacts

Pathway Genomics
Zak Pugh, 858-217-4358
pr@pathway.com
www.pathway.com